Application Notes: Immunoreactivity: 80-120 % compared to the reference sample in an ELISA test
Immobilized 2019-nCoV Nucleocapsid Protein (Catorb1228242) at 5.0µg/ml (100µL/well) can bind Recombinant anti-2019-nCoV NP ScFv (4A6), the EC50 is less than 6.65ng/ml.
Stability is confirmed by binding ability with 2019-nCoV Nucleocapsid Protein (Catorb1228242). The result showed that product bioactivity is no significant differences among these samples.
Please note that pair recommendations are based on results obtained by our laboratory. Equally good results may be obtained using other pairs and therefore these recommendations are only indicative.
Freeze-thaw stability is tested by repeated freeze-thaw cycles. The result showed that product bioactivity is no significant differences after freeze-thawing 14 times.
* VAT and and shipping costs not included. Errors and price changes excepted